Key Study Summaries
What are the key study summaries?
In every speciality there are studies that shape the way how we mange certain conditions; these studies are called key studies. Knowledge of and understanding the key studies, as well as critically appraising them, is key to safe and successful management. We launched the key study summaries project with the aim to bring all the important studies in gynaecology to one place and make it easily accessible no matter where you are.
We are always looking for authors to contribute in the key study summaries and other projects. If you wish to submit your contribution please follow the link. We look forward hearing from you.
A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared with Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix.
To determine whether postoperative pelvic radiotherapy following radical hysterectomy and pelvic node dissection would reduce the rate of reoccurrence and decrease mortality in Stage IB cancer patients.
Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients with Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy
To investigate whether the addition of (HIPEC) to interval cytoreductive surgery would improve outcomes among patients who were receiving neoadjuvant chemotherapy for stage III epithelial cancer
A Phase 3 Trial of Bevacizumab in Ovarian Cancer. The study question was to investigate the addition of bevacizumab to standard chemotherapy in the first-line treatment of ovarian cancer.
The study question was to test the effectiveness of intraperitoneal Cisplatin and Paclitaxel in addition to intravenous Paclitaxel in women with stage III ovarian cancer who had optimal debulking surgery.
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer JGOG 2008
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer (GOG258). The study question was to evaluate the use of chemoradiotherapy as compared with the use of chemotherapy alone in locally advanced endometrial cancer.
To determine if vaginal cuff brachytherapy and chemotherapy (VCB/C) increases recurrence-free survival compared with pelvic radiation therapy (RT) in high-risk early-stage endometrial carcinoma
gestational trophoblastic neoplasia
What You Get
- Your contribution will help large number of gynaecologists who visit our website do a better job .
- Being one of our authors will help promote your academic and writing skills.
- We will help you promote your publications through our social media presence.
- Being part of “GynaeFellow” family will enable you to gain contacts which may enable you to advance your career.